Combination of brimonidine and timolol for topical ophthalmic use
US9474751B1 · kind B1 · utility
2Cited by
36References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2016 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | Jun 24, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions comprising brimonidine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.